Emil D. Kakkis, President & CEO at Ultragenyx Pharmaceutical Inc. (RARE), sold 5,780 shares at $65.52 ($379K) on 2019-03-05, disclosed to the SEC on 2019-04-17.
Open-market sale of $379k RARE by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.52 | 2,890 | $189K | 50.0% |
| 2 | $65.52 | 2,890 | $189K | 50.0% |
| Total | $65.52 avg | 5,780 | $379K | 100% |
| Filing → |
| RARE | SELL | 2024-12-31 | $990K | — | Filing → |
| RARE | SELL | 2024-12-11 | $414K | — | Filing → |
| RARE | SELL | 2024-09-05 | $1.1M | — | Filing → |